AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Inogla-M 500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Wockhardt Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Inogla-M 500 Tablet ER

Diabeta-Duo 500mg Extended Release combines two medications to manage elevated blood glucose in type 2 diabetes. This helps avert serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. Diabeta-Duo 500mg ER may be used independently or with other diabetes treatments. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health, glucose levels, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing is crucial for efficacy; discontinuation should only occur under medical supervision. Effective blood sugar control lessens the risk of future complications. Maintaining your prescribed diet and exercise plan is vital. Lifestyle choices significantly impact diabetes management. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, and headaches. Low blood sugar (hypoglycemia) is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to identify and manage this. This medication isn't suitable for all. Inform your doctor of any prior kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before use. Pregnant or lactating individuals should seek medical advice. Interactions with other medications are possible; provide a complete medication list to your doctor. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor your kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Inogla-M 500 Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Inogla-M 500 Tablet ER

Managing type 2 diabetes

Major Benefits of Inogla-M 500 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Inogla-M 500 Tablet ER whole; avoid chewing, crushing, or breaking it. It should be administered with a meal.

Common Side effects of Inogla-M 500 Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Inogla-M 500 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Inogla-M 500 Extended-Release Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with food.

How Inogla-M 500 Tablet ER works:

Extended-release Inogla-M 500 tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Inogla-M 500 Tablet ER and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Inogla-M 500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Inogla-M 500 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Inogla-M 500 Tablet ER on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Inogla-M 500 Tablet ER, potentially requiring a modified dosage. Severe kidney disease contraindicates the use of Inogla-M 500 Tablet ER. Physician consultation is recommended. Kidney function should be regularly assessed during treatment with this medication.

LiverLiverUNSAFE

Extended-release Inogla-M 500mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take Inogla-M 500 Tablet ER :

Should you forget a dose of Inogla-M 500 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Inogla-M 500 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Inogla-M 500 Tablet ER

Inogla-M 500 Tablet ER is safe when used as directed by your doctor. However, even with proper usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent side effects to your physician.
Inogla-M 500 Tablet ER rarely causes low blood sugar (hypoglycemia) by itself. However, hypoglycemia can happen if you don't eat enough while taking it. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if you skip meals, drink alcohol, overexert yourself, or use other diabetes medication. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice on hand.
Nausea and vomiting are possible side effects of Inogla-M 500 Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always seek medical advice before taking additional medication.
Inogla-M 500 Tablet ER is contraindicated in patients allergic to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Inogla-M 500 Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect involving elevated blood lactic acid levels. This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users, hence its avoidance in these groups. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Inogla-M 500 Tablet ER and seek immediate medical attention.
Prolonged use of Inogla-M 500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), cognitive changes, and balance problems (ataxia). If you experience any of these symptoms, consult your physician for potential vitamin B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Inogla-M 500 Tablet ER
154
MRP 179
13% off